Concepedia

Sayo Soda

SS

Statistics

Publications

5

Citations

126

H-Index

5

Active since

2012

Affiliations

Dokkyo Medical University(Current)

Chiba University

Tochigi Cancer Center

Juntendo University

Saitama Medical University

Sayo Soda is an author at Dokkyo Medical University specializing in medicine, oncology, and egfr inhibition.

Publications per year

2012–2024

5

Publications

5

Osimertinib, a third‐generation EGFR tyrosine kinase inhibitor: A retrospective multicenter study of its real‐world efficacy and safety in advanced/recurrent non‐small cell lung carcinoma

Takayuki Kishikawa, Takashi Kasai, Masahiko Okada et al. · Thoracic Cancer · 2020 · 38 citations · Full text

, , +15

Lipid Accumulation in Peripheral Blood Dendritic Cells and Anticancer Immunity in Patients with Lung Cancer

Ryo Arai, Sayo Soda, Tomoko Okutomi et al. · Journal of Immunology Research · 2018 · 35 citations · Full text

, , +12

Prognostic Factors and Efficacy of First-Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study

Ryo Ko, Takehito Shukuya, Yusuke Okuma et al. · The Oncologist · 2018 · 29 citations · Full text

, , +9

Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)

Naoya Nishioka, Hisao Imai, Masahiro Endo et al. · Targeted Oncology · 2024 · 13 citations · Full text

, , +13

Riluzole-induced Lung Injury in Two Patients with Amyotrophic Lateral Sclerosis

T. Kakuta, Hirokuni Hirata, Sayo Soda et al. · Internal Medicine · 2012 · 11 citations · Full text

, , +17

1–5 of 5